Patent Term Restoration: How Pharmaceutical Companies Legally Extend Drug Exclusivity
January 4, 2026 by Maxwell Harrington
Patent term restoration lets pharmaceutical companies recover time lost during FDA approval, extending drug exclusivity by up to five years. Learn how the Hatch-Waxman Act works, who qualifies, and why it's critical for drug innovation.
QT Prolongation and Sudden Cardiac Death from Medications: Key Risk Factors to Watch For
January 3, 2026 by Maxwell Harrington
QT prolongation from medications can lead to sudden cardiac death. Learn which drugs pose the highest risk, who's most vulnerable, and how to prevent life-threatening arrhythmias before it's too late.
Subscribe to FDA Safety Communications: Never Miss an Alert
January 3, 2026 by Maxwell Harrington
Subscribe to FDA Safety Communications to get real-time alerts about drug recalls, medical device risks, and food safety issues. Learn how keyword-based email notifications can protect you and your family.
Antibiotic Combination Products: Generic Availability and What It Means for Patients
December 31, 2025 by Maxwell Harrington
Generic antibiotic combination products offer the same effectiveness as brand-name versions at a fraction of the cost. Learn how they work, why they’re not always available, and how they’re changing infection treatment in the U.S.
How to Save Money with Generics Without Sacrificing Safety
December 29, 2025 by Maxwell Harrington
Learn how to save hundreds or even thousands on prescriptions by switching to generic medications without risking your health. Discover when generics are safe, when to be cautious, and how to use them wisely.
Pitavastatin and Diabetes Risk: What You Need to Know About Its Metabolic Effects
December 28, 2025 by Maxwell Harrington
Pitavastatin is a statin with a more favorable metabolic profile than others, making it a preferred choice for people with prediabetes or insulin resistance. Learn how it affects blood sugar, how it compares to other statins, and who should consider switching.
How the FDA Inspects Drugs Entering the U.S. to Ensure Safety and Quality
December 27, 2025 by Maxwell Harrington
Learn how the FDA monitors and inspects every drug entering the U.S. to ensure safety, from risk-based screening to the end of the $800 loophole. Understand what gets detained, why, and how the system protects patients.
Biologic Patent Protection: When Biosimilars Can Enter the U.S. Market
December 26, 2025 by Maxwell Harrington
Biologic patent protection in the U.S. grants 12 years of exclusivity before biosimilars can enter the market. Complex regulations, patent thickets, and high development costs delay competition, keeping prices high and patients paying more than they should.
Generic Prescribing Guidelines: Professional Recommendations for Clinicians
December 24, 2025 by Maxwell Harrington
Generic prescribing saves billions, improves adherence, and reduces errors-but only when done right. Learn when to use generics, when to avoid them, and how to explain the switch to patients.
Blue Light and Sleep: How to Set Screen Time Limits for Deeper Rest
December 23, 2025 by Maxwell Harrington
Blue light from screens suppresses melatonin and delays sleep. Limit screen time 60-90 minutes before bed, use filters wisely, and replace scrolling with calming routines for deeper rest.